(Q45889426)

17 December 2017

title

Correlation of CpG island methylator phenotype with poor prognosis in hepatocellular carcinoma (English)

1 reference

17 December 2017

1 reference

2

Changsong Zhang

1 reference

17 December 2017

author name string

Yue Cheng

1

1 reference

17 December 2017

Jun Zhao

3

1 reference

17 December 2017

Chenyang Wang

4

1 reference

17 December 2017

Yun Xu

5

1 reference

17 December 2017

Zhipeng Han

6

1 reference

17 December 2017

Guocheng Jiang

7

1 reference

17 December 2017

Xianling Guo

8

1 reference

17 December 2017

Rong Li

9

1 reference

17 December 2017

Xinxin Bu

10

1 reference

17 December 2017

Mengchao Wu

11

1 reference

17 December 2017

Lixin Wei

12

1 reference

17 December 2017

publication date

29 October 2009

1 reference

17 December 2017

Experimental and Molecular Pathology

published in

1 reference

17 December 2017

volume

88

1 reference

17 December 2017

issue

1

1 reference

17 December 2017

page(s)

112-117

1 reference

17 December 2017

Alterations in DNA Methylation: A Fundamental Aspect of Neoplasia

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.008

Underlying liver disease, not tumor factors, predicts long-term survival after resection of hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.008

CpG island methylation status in gastric carcinoma with and without infection of Epstein-Barr virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.008

Aberrant CpG-island methylation has non-random and tumour-type-specific patterns.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.008

Tissue inhibitor of metalloproteinase-3 (TIMP-3) gene is methylated in the development of esophageal adenocarcinoma: loss of expression correlates with poor prognosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.008

Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.008

Hepatocellular carcinoma: an epidemiologic view

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.008

Hypermethylation of the spleen tyrosine kinase promoter in T-lineage acute lymphoblastic leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.008

Prognostic analysis of E-cadherin gene promoter hypermethylation in patients with surgically resected, node-positive, diffuse gastric cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.008

Gene silencing in cancer in association with promoter hypermethylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.008

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.008

p53 mutation is a poor prognostic indicator for survival in patients with hepatocellular carcinoma undergoing surgical tumour ablation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.008

The fundamental role of epigenetic events in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.008

Relationships between chromatin organization and DNA methylation in determining gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.008

Hepatic resection for hepatocellular carcinoma. An audit of 343 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.008

The power and the promise of DNA methylation markers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.008

X chromosome imprinting and inactivation in the early mammalian embryo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.008

Aberrant CpG Island Hypermethylation Along Multistep Hepatocarcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.008

Epigenetic alterations in neuroendocrine tumors: methylation of RAS-association domain family 1, isoform A and p16 genes are associated with metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.008

Correlation of laterally spreading type and JC virus with methylator phenotype status in colorectal adenoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.008

Accumulation of DNA methylation is associated with tumor stage in gastric cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.008

Tumor microvessel density as a predictor of recurrence after resection of hepatocellular carcinoma: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.008

Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.008

Promoter hypermethylation leads to decreased APC mRNA expression in familial polyposis and sporadic colorectal tumours, but does not substitute for truncating mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.008

Methylation enrichment pyrosequencing: combining the specificity of MSP with validation by pyrosequencing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.008

DNA methylation and environmental exposures in human hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.008

Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.008

CpG island methylator phenotype predicts progression of malignant melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.008

CpG island methylator phenotype in colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.008

Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.008

CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.008

Favorable surgical outcomes in patients with early hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.008

Genetics supersedes epigenetics in colon cancer phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.008

A randomized phase III study of doxorubicin versus cisplatin/interferon alpha-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.008

The outcome of liver transplantation in patients with hepatocellular carcinoma in the United States between 1988 and 2001: 5-year survival has improved significantly with time

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.008

Frequent epigenetic inactivation of spleen tyrosine kinase gene in human hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.008

Methylation profiling of twenty four genes and the concordant methylation behaviours of nineteen genes that may contribute to hepatocellular carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.008

CpG island methylator phenotype association with elevated serum alpha-fetoprotein level in hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.008

10.1016/J.YEXMP.2009.10.008

7 January 2021

Identifiers

DOI

1 reference

17 December 2017

1 reference

17 December 2017